Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Public ClinicalTrials.gov record NCT00003160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Paclitaxel (Taxol) Administered as a Weekly One Hour Infusion in Patients With Taxol/Platinum-Refractory Stage III and IV Ovarian Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating women with stage III or stage IV ovarian cancer that is refractory to paclitaxel and platinum-based regimens.
Study identification
- NCT ID
- NCT00003160
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1997 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 20, 2011
Started 1997
United States locations
- U.S. sites
- 18
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oncology Center at Providence Park | Mobile | Alabama | 36608 | — |
| Hematology Associates, Ltd. | Phoenix | Arizona | 85013 | — |
| Highlands Oncology Group, P.A. | Fayetteville | Arkansas | 72703 | — |
| Cancer Center of Santa Barbara | Santa Barbara | California | 93105 | — |
| Good Samaritan Medical Center | West Palm Beach | Florida | 33401 | — |
| Decatur Memorial Hospital Cancer Care Institute | Decatur | Illinois | 62526 | — |
| Creighton University Cancer Center | Omaha | Nebraska | 68131-2197 | — |
| Jersey Shore Cancer Center | Neptune City | New Jersey | 07753 | — |
| Women's Health Center at Albany Medical Center | Albany | New York | 12209 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28232-2861 | — |
| Akron General Medical Center | Akron | Ohio | 44302 | — |
| Oncology/Hematology Care, Inc. | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Cancer Center | Cleveland | Ohio | 44195 | — |
| Women's Cancer Center of Central PA, P.C. | Harrisburg | Pennsylvania | 17105-8700 | — |
| Women and Infants Hospital of Rhode Island | Providence | Rhode Island | 02905 | — |
| Brookview Research, Inc. | Nashville | Tennessee | 37203 | — |
| Harrington Cancer Center | Amarillo | Texas | 79106 | — |
| Rockwood Clinic P.S. | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2011 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00003160 live on ClinicalTrials.gov.